Investor Presentaiton slide image

Investor Presentaiton

Reagent & Services Instrument Medical Diagnosis - Core Product Biochemical Immunodiagnostic F-C800 F-C800p 77 Routine Biochemical Reagents XPT 5MyCare (Spiritual) F-i1000 Molecule + Respiratory Microbiology & Tuberculosis POCT Chronic Diseases POCT Acute Infections Early Tumor Screening SLAN Amplifier Rapid Fluorescence 528 318 Molecule POCT GU-2 MLA F-i3000 TB ES-15 COVID-19 Extractor GULP Rapid Antigen Test Tumor Markers 15, Thyroid Function8, Gastric Function3, Infection3, Carbohydrate Metabolism2, Sexhormone8 12 Routine PCR COVID-19 RT- PCR Detection Kit Universal Extraction Reagent Monkeypox PCR Detection Kit NG-Test Blood Glucose Disk Susceptibility Test for Fungal/Bacteria Uric Acid (Ag) COVID-19 Rapid Antigen Test G-TEST Tuberculosis I-SPOT Blood Lipid • • • 35 Medical Diagnosis 1H22 Major Progress In-House Development Collaboration Services Promoting the integration of medical diagnosis segment to continuously improve the R&D and manufacturing capabilities of diagnostic instruments F-C800p Automatic Biochemical Analyzer launched in June 2022, together with the F-i3000 Automated Chemiluminescence Immunoassay Analyzer, formed Fosun Diagnostics biochemical immunoassay pipeline to meet the clinical diagnostic testing needs Self-developed COVID-19 Rapid Antigen Test was approved by NMPA in April 2022. It has received EU CE certification and FDA EUA, been included in the EU Common list of COVID-19 antigen tests and completed BfArM registration in Germany Self-developed Monkeypox PCR Detection Kit received EU CE certification in May 2022
View entire presentation